Background: Many cases of hereditary breast cancer are due to mutations in
either the BRCA1 or the BRCA2 gene. The histopathological changes in these
cancers are often characteristic of the mutant gene. We hypothesized that t
he genes expressed by these two types of tumors are also distinctive, perha
ps allowing us to identify cases of hereditary breast cancer on the basis o
f gene-expression profiles.
Methods: RNA from samples of primary tumors from seven carriers of the BRCA
1 mutation, seven carriers of the BRCA2 mutation, and seven patients with s
poradic cases of breast cancer was compared with a microarray of 6512 compl
ementary DNA clones of 5361 genes. Statistical analyses were used to identi
fy a set of genes that could distinguish the BRCA1 genotype from the BRCA2
genotype.
Results: Permutation analysis of multivariate classification functions esta
blished that the gene-expression profiles of tumors with BRCA1 mutations, t
umors with BRCA2 mutations, and sporadic tumors differed significantly from
each other. An analysis of variance between the levels of gene expression
and the genotype of the samples identified 176 genes that were differential
ly expressed in tumors with BRCA1 mutations and tumors with BRCA2 mutations
. Given the known properties of some of the genes in this panel, our findin
gs indicate that there are functional differences between breast tumors wit
h BRCA1 mutations and those with BRCA2 mutations.
Conclusions: Significantly different groups of genes are expressed by breas
t cancers with BRCA1 mutations and breast cancers with BRCA2 mutations. Our
results suggest that a heritable mutation influences the gene-expression p
rofile of the cancer. (N Engl J Med 2001;344:539-48.) Copyright (C) 2001 Ma
ssachusetts Medical Society.